Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Two injured after fallen drone debris hits houses in Saudi Arabia
China confirms three ships passed through Strait of Hormuz
Three UN peacekeepers killed in Lebanon as Israeli strikes pummel south
Russian attacks kill two, injure dozens
Iran calls US peace proposals 'unrealistic', Trump issues new warning to Tehran
Japan to coordinate on energy with Indonesia as Iran war disrupts supplies
Mexican immigrant dies in US immigration custody, ICE says
Israel passes death penalty law for Palestinians convicted of lethal attacks
